Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors

Current Breast Cancer Reports(2025)10.1007/s12609-025-00582-5Source: DataRank Database

Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors is a research paper published in Current Breast Cancer Reports (2025). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.35)OA: hybridTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Mateusz Opyrchal ORCID,Alo Ray ORCID

Live enrichment

PubMed:40521389 PMC:PMC12162764 OpenAlex:https://openalex.org/W4411251115

National Institutes of Health

Grant: P30 CA082709

NCI NIH HHS

Grant: F30 CA254327

National Institutes of Health

Grant: 3P30CA082709-16S3

Indiana University Melvin and Bren Simon Cancer Center Support Grant

Vera Bradley Foundation for Breast Cancer

FWCI

6.35

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s12609-025-00582-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s12609-025-00582-5.pdf

publisherhttps://link.springer.com/article/10.1007/s12609-025-00582-5

journalhttps://doi.org/10.1007/s12609-025-00582-5

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40521389

Fields of Study

PARP inhibition in cancer therapyDNA Repair MechanismsBRCA gene mutations in cancer03 medical and health sciences0302 clinical medicine

Keywords

PARP1Homologous recombinationPoly ADP ribose polymeraseTolerabilitySynthetic lethalityOlaparibPolymeraseMedicinePharmacologyBiologyDNA repairCancer researchGeneticsDNAAdverse effectDNA damageParp2Double-strand Breaks (Dsbs)Single-strand Breaks (Ssbs)Homologous Recombination Deficiency (Hrd)Homologous Recombination Repair (Hrr)Review

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors

FAIR Checklist

Authors (2)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)